NO20053368D0 - Fremgangsmate for fremstilling av en farmasoytisk ren polymorf I av olanzapin. - Google Patents

Fremgangsmate for fremstilling av en farmasoytisk ren polymorf I av olanzapin.

Info

Publication number: NO20053368D0
Authority: NO; Norway
Prior art keywords: olanzapine; preparation; pharmaceutically pure; pure polymorph; polymorph
Prior art date: 2002-12-20

Application number

NO20053368A

Other languages

English (en)

Other versions

NO20053368L (no

Inventor

Tomasz Stawinsky

Zbigniew Majka

Original Assignee

Adamed Sp Zoo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-20

Filing date

2005-07-11

Publication date

2005-07-11

2005-07-11 Application filed by Adamed Sp Zoo filed Critical Adamed Sp Zoo

2005-07-11 Publication of NO20053368L publication Critical patent/NO20053368L/no

2005-07-11 Publication of NO20053368D0 publication Critical patent/NO20053368D0/no

Links

KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 title 1
229960005017 olanzapine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20053368A 2002-12-20 2005-07-11 Fremgangsmate for fremstilling av en farmasoytisk ren polymorf I av olanzapin. NO20053368D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PL357928A PL202856B1 (pl)	2002-12-20	2002-12-20	Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny
PCT/IB2003/005931 WO2004056833A1 (en)	2002-12-20	2003-12-15	A process for the preparation of a pharmaceutically pure polymorphic form i of olanzapine

Publications (2)

Publication Number	Publication Date
NO20053368L NO20053368L (no)	2005-07-11
NO20053368D0 true NO20053368D0 (no)	2005-07-11

Family

ID=32678125

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053368A NO20053368D0 (no)	2002-12-20	2005-07-11	Fremgangsmate for fremstilling av en farmasoytisk ren polymorf I av olanzapin.

Country Status (13)

Country	Link
EP (1)	EP1581537B1 (no)
CN (1)	CN100354280C (no)
AU (1)	AU2003292452A1 (no)
BR (1)	BR0317594A (no)
CA (1)	CA2506663A1 (no)
DE (1)	DE60317712D1 (no)
ES (1)	ES2294333T3 (no)
HR (1)	HRP20050549A2 (no)
MX (1)	MXPA05006711A (no)
NO (1)	NO20053368D0 (no)
PL (1)	PL202856B1 (no)
UA (1)	UA82213C2 (no)
WO (1)	WO2004056833A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7323459B2 (en)	2002-12-24	2008-01-29	Teva Pharmaceutical Industries Ltd.	Crystal forms, methods for their preparation and method for preparation of olanzapine
WO2006025065A1 (en) *	2004-08-31	2006-03-09	Lee Pharma Private Limited	A process for the preparation of anhydrous olanzopine hydrochloride of form-1
WO2006027800A1 (en)	2004-09-06	2006-03-16	Shasun Chemicals And Drugs Limited	A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine
GB0522473D0 (en)	2005-11-03	2005-12-14	Actavis Group	A pharmaceutical formulation
WO2007144901A1 (en) *	2006-06-12	2007-12-21	Jubilant Organosys Limited	Process for stabilization of olanzapine polymorphic form i
PL381564A1 (pl)	2007-01-22	2008-08-04	Koźluk Tomasz Nobilus Ent	Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny
EP2292624A1 (en)	2009-07-20	2011-03-09	LEK Pharmaceuticals d.d.	Process for the purification of olanzapine
CN103910747B (zh) *	2014-04-24	2016-03-23	东南大学	一种奥氮平药物晶型f及其制备方法
CN109456336A (zh) *	2017-09-06	2019-03-12	万全万特制药江苏有限公司	奥氮平的精制方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5229382A (en) *	1990-04-25	1993-07-20	Lilly Industries Limited	2-methyl-thieno-benzodiazepine
GB9009229D0 (en) *	1990-04-25	1990-06-20	Lilly Industries Ltd	Pharmaceutical compounds
US5631250A (en) *	1995-03-24	1997-05-20	Eli Lilly And Company	Process and solvate of 2-methyl-thieno-benzodiazepine
EG23659A (en) *	1995-03-24	2007-03-26	Lilly Co Eli	Process and crystal forms of methyl-thieno-benzodiazepine
CR5278A (es) *	1995-03-24	1996-07-04	Lilly Co Eli	Formulacion oral de 2-metil-tieno-benzodiacepina
US6348458B1 (en) *	1999-12-28	2002-02-19	U & I Pharmaceuticals Ltd.	Polymorphic forms of olanzapine
SK2502003A3 (en) *	2000-08-31	2004-03-02	Reddys Lab Ltd Dr	Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
PL196814B1 (pl) *	2002-05-17	2008-02-29	Inst Farmaceutyczny	Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
US7297789B2 (en) *	2002-05-31	2007-11-20	Sandoz, Inc.	Process of preparation of olanzapine form I
SI21270A (sl) *	2002-07-15	2004-02-29	Krka, Tovarna Zdravil, D.D., Novo Mesto	Kristalne oblike olanzapina in postopki za njihovo pripravo

2002
- 2002-12-20 PL PL357928A patent/PL202856B1/pl unknown
2003
- 2003-12-15 AU AU2003292452A patent/AU2003292452A1/en not_active Abandoned
- 2003-12-15 ES ES03768031T patent/ES2294333T3/es not_active Expired - Lifetime
- 2003-12-15 MX MXPA05006711A patent/MXPA05006711A/es unknown
- 2003-12-15 HR HR20050549A patent/HRP20050549A2/hr not_active Application Discontinuation
- 2003-12-15 CN CNB200380106963XA patent/CN100354280C/zh not_active Expired - Fee Related
- 2003-12-15 CA CA002506663A patent/CA2506663A1/en not_active Abandoned
- 2003-12-15 WO PCT/IB2003/005931 patent/WO2004056833A1/en not_active Ceased
- 2003-12-15 EP EP03768031A patent/EP1581537B1/en not_active Expired - Lifetime
- 2003-12-15 DE DE60317712T patent/DE60317712D1/de not_active Expired - Lifetime
- 2003-12-15 BR BR0317594-4A patent/BR0317594A/pt not_active IP Right Cessation
- 2003-12-15 UA UAA200507207A patent/UA82213C2/uk unknown
2005
- 2005-07-11 NO NO20053368A patent/NO20053368D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1581537B1 (en)	2007-11-21
MXPA05006711A (es)	2005-11-23
CA2506663A1 (en)	2004-07-08
HRP20050549A2 (en)	2005-12-31
AU2003292452A1 (en)	2004-07-14
CN1729195A (zh)	2006-02-01
UA82213C2 (uk)	2008-03-25
PL202856B1 (pl)	2009-07-31
NO20053368L (no)	2005-07-11
EP1581537A1 (en)	2005-10-05
CN100354280C (zh)	2007-12-12
WO2004056833A1 (en)	2004-07-08
PL357928A1 (en)	2004-06-28
BR0317594A (pt)	2005-11-22
ES2294333T3 (es)	2008-04-01
DE60317712D1 (de)	2008-01-03

Similar Documents

Publication	Publication Date	Title
IL175860A0 (en)	2006-10-05	Method for the production of a solid, orally applicable pharmaceutical composition
NO20053115D0 (no)	2005-06-24	Fremgangsmate for fremstilling av 2'-forgrenede nukleosider.
MA28641B1 (fr)	2007-06-01	Procede pour la fabrication d'un vaccin contre la grippe
NO20031694L (no)	2003-04-11	Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
NO20043000L (no)	2004-07-13	Et preparat for behandling av nevrocerebrovaskulaere sykdommer
IS7755A (is)	2005-03-17	Aðferð við framleiðslu á (S,S)-cis-2-benshýdríl-3-bensýlamínókínuklídín
IL181766A0 (en)	2007-07-04	A process for the preparation of [1,4,5]-oxadiazepine derivatives
MXPA03007087A (es)	2003-11-18	Procedimiento para fabricacion de derivados de acido fenilacetico.
DK1546122T3 (da)	2008-03-03	Fremgangsmåde til fremstilling af valsartan
EE200300537A (et)	2004-04-15	Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
IL162817A0 (en)	2005-11-20	Process for the manufacture of organic compounds
GB0204129D0 (en)	2002-04-10	Process for the manufacture of organic compounds
IS7153A (is)	2004-02-13	Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu
NO20044814L (no)	2004-01-07	Fremgangsmate for fremstilling av combretastaniner
NO20053368D0 (no)	2005-07-11	Fremgangsmate for fremstilling av en farmasoytisk ren polymorf I av olanzapin.
NO20052158L (no)	2005-05-02	Fremgangsmate for fremstilling av en benzimidazolforbindelse.
GB0210234D0 (en)	2002-06-12	Process for the manufacture of organic compounds
NO20042640L (no)	2004-06-23	Fremgangsmate for fremstilling av ekinocandinderivater
IL174592A0 (en)	2006-08-20	Processes for the preparation of a polymorph of fluvastantin sodium
NO20035586D0 (no)	2003-12-15	Fremgangsmåte for fremstilling av cykloheksanol-derivater
FI20020593A0 (fi)	2002-03-27	Menetelmä konjugoidun linolihapon valmistamiseksi
NO20052471D0 (no)	2005-05-23	Fremgangsmate for fremstilling av 3-metyltiopropanal.
NO20044332L (no)	2005-01-17	Forbedret fremgangsmate for fremstilling av nevirapine
IL165137A0 (en)	2005-12-18	Process for the preparation of thioalkylamine derivatives
AU2002367890A1 (en)	2003-11-10	Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate

Legal Events

Date	Code	Title	Description
2012-01-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application